srch srch

Pine bark relieves menopausal symptoms and boosts new heart health in new study

Wednesday May 24, 2017

Supplementation of Pycnogenol, a French maritime pine bark extract, has been found to reduce the risk of high blood pressure and cholesterol levels – often related to perimenopausal women, reveals a new study.


The findings also highlighted a significant decrease in most of the major symptoms: fatigue, hot flashes, irregular periods, and night sweat and an improvement in mood.


The menopause is clinically defined as a period (a year) after the final menstrual period. Meanwhile the perimenopause is the transition period before the menopause. Women show an increased risk of cardiovascular disease at the onset of menopause as the body decreases production of estrogen.

Pycnogenol is an antioxidant and has anti-inflammatory properties. 



The results of this new clinical study align with previous research on Pycnogenol showing a reduction of risk factors contributing to cardiovascular disease on menopausal women.

Supplementation with Pycnogenol reduced and normalised elevated cardiovascular risk factors often related to perimenopause: cholesterol, triglycerides, blood pressure and blood glucose and reduced associated symptoms.

In the clinical study, 70 women aged 40 to 50 were split into two groups – one given daily supplementation of 100mg of Pycnogenol while the other a placebo – over an eight-week period. All participants were advised to follow a self-improvement routine of exercise, rest and a healthy diet.



After eight weeks, the Pycnogenol group reported significantly reduced perimenopause symptoms related to hot flashes, night sweat, and mood. This group also showed a significant reduction of perimenopause-related cardiovascular risks such as lower blood pressure.

The results from the Pycnogenol group include:


- Significant relief of hot flashes (41 percent improvement)

- Reduction of night sweat (33 percent improvement)

- Normalization of irregular periods (67 percent improvement)

- Significant improvement of mood (25 percent improvement)


 Reducing perimenopausal cardiovascular risk


Researchers tested again six months after the initial testing period and found significant reduction of cardiovascular risk indicators, including:

- Normalization of systolic blood pressure (8 percent improvement)

- Reduction of fasting blood glucose (9 percent improvement)

- Significant reduction of oxidative stress (22 percent improvement)

- Improvement of triglycerides levels (11 percent improvement)

This research also advances previous studies indicating Pycnogenol’s ability to significantly reduce oxidative stress, a key determinant of high CRP levels and inflammation.

Commenting on the findings, natural health expert and author Dr. Fred Pescatore, said:
“What’s really interesting about this study is the drastic improvement of menopause transition symptoms in the Pycnogenol group. Most women spend about one-third of their lives in menopause and post-menopause so it’s important to find safe and effective natural products to manage those troublesome, and sometimes problematic, symptoms.” 

Experts recommend adopting a ‘best practice’ regimen consisting of a healthy diet and exercise to help manage symptoms of perimenopause, but the study findings for Pycnogenol are encouraging for women experiencing persistent disruptive symptoms.

Pycnogenol is a natural plant extract originating from the bark of the maritime pine that grows along the coast of southwest France and is found to contain a unique combination of procyanidins, bioflavonoids and phenolic acids, which offer extensive natural health benefits.


Click here to read the full study


TAGS: Nutrition News and Viewspycnogenol


Back To Top

The Leading Brand of ethical vitamins